The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents
Shiwen Yu,Jinling Zheng,Yan Zhang,Dandan Meng,Yujue Wang,Xiaoyu Xu,Na Liang,Shayibai Shabiti,Xu Zhang,Zixi Wang,Zehua Yang,Pengbing Mi,Xing Zheng,Wenjun Li,Hongfei Chen
DOI: https://doi.org/10.1016/j.bmc.2023.117486
IF: 3.461
2023-09-01
Bioorganic & Medicinal Chemistry
Abstract:Chemotherapy is the mainstay in the treatment of breast cancer. However, many drugs that are commonly used in clinical practice have a high incidence of side effects and multidrug resistance (MDR), which is mainly caused by overexpression of drug transporters and related enzymes in breast cancer cells. In recent years, researchers have been working hard to find newer and safer drugs to overcome MDR in breast cancer. In this review, we provide the molecule mechanism of MDR in breast cancer, categorize potential lead compounds that inhibit single or multiple drug transporter proteins, as well as related enzymes. Additionally, we have summarized the structure-activity relationship (SAR) based on potential breast cancer MDR modulators with lower side effects. The development of novel approaches to suppress MDR is also addressed. These lead compounds hold great promise for exploring effective chemotherapy agents to overcome MDR, providing opportunities for curing breast cancer in the future.
biochemistry & molecular biology,chemistry, medicinal, organic